Actionable news
0
All posts from Actionable news
Actionable news in HALO: Halozyme Therapeutics, Inc.,

Today's Dead Cat Bounce Stock: Halozyme Therapeutics (HALO)

Trade-Ideas LLC identified Halozyme Therapeutics ( HALO) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Halozyme Therapeutics as such a stock due to the following factors:

  • HALO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $14.2 million.
  • HALO has traded 295,681 shares today.
  • HALO is up 3.4% today.
  • HALO was down 6.1% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in HALO with the Ticky from Trade-Ideas. See the FREE profile for HALO NOW at Trade-Ideas More details on HALO: Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Currently there are 4 analysts that rate Halozyme Therapeutics a buy, 1 analyst rates it a sell, and none rate it a hold. The average volume for Halozyme Therapeutics has been 1.6 million shares per day over the past 30 days. Halozyme has a market cap of $1.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.81 and a short float of 21.3% with 12.64 days to cover. Shares are down 50.8% year-to-date as of the close of trading on Friday. EXCLUSIVE OFFER: See inside Jim Cramer's...


More